1 |
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983;17:37-49.
|
2 |
Cho MJ, Bae JN, Suh GH, Hahm BJ, Kim JK, Lee DW, et al. Validation of Geriatric Depression Scale, Korean Version (GDS) in the Assessment of DSM-III-R Major Depression. J Korean Neuropsychiatr Assoc 1999;38:48-63.
|
3 |
Farlow MR. Alzheimer' s disease: clinical implications of the apolipoprotein E genotype. Neurology 1997;48(5 Suppl 6):S30-S34.
|
4 |
Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, et al. Cognitive change and the APOE epsilon 4 allele. Nature 2002;418:932.
DOI
|
5 |
Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, et al. Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc 2007;55:1777-1785.
DOI
|
6 |
Riley KP, Snowdon DA, Saunders AM, Roses AD, Mortimer JA, Nanayakkara N. Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study. J Gerontol B Psychol Sci Soc Sci 2000;55:S69-S75.
DOI
|
7 |
Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999;282:40-46.
DOI
|
8 |
Tulving E. Multiple memory systems and consciousness. Hum Neurobiol 1987;6:67-80.
|
9 |
Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, Albert M, et al. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 2008;70(19 Pt 2):1842-1849.
DOI
|
10 |
Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, et al. Impact of apolipoprotein E4-cerebrospinal fluid -amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement 2011;7:514-520.
DOI
|
11 |
Tulving E. Elements of episodic memory. Oxford, England: Clarendon Press;1983.
|
12 |
Nyberg L, Maitland SB, Rönnlund M, Bäckman L, Dixon RA, Wahlin A, et al. Selective adult age differences in an age-invariant multifactor model of declarative memory. Psychol Aging 2003;18:149- 160.
DOI
|
13 |
Levy JA, Bergeson J, Putnam K, Rosen V, Cohen R, Lalonde F, et al. Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer' s disease. J Int Neuropsychol Soc 2004;10:362-370.
|
14 |
De Blasi S, Montesanto A, Martino C, Dato S, De Rango F, Bruni AC, et al. APOE polymorphism affects episodic memory among non demented elderly subjects. Exp Gerontol 2009;44:224-227.
DOI
|
15 |
Small BJ, Rosnick CB, Fratiglioni L, Backman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004;19: 592-600.
DOI
|
16 |
Parasuraman R, Greenwood PM, Sunderland T. The apolipoprotein E gene, attention, and brain function. Neuropsychology 2002;16:254- 274.
DOI
|
17 |
Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet 1999;63(Pt4):301-310.
DOI
|
18 |
Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-1122.
DOI
|
19 |
Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992; 9:155-167.
DOI
|
20 |
Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
DOI
|
21 |
Bertoni-Freddari C, Fattoretti P, Solazzi M, Giorgetti B, Di Stefano G, Casoli T, et al. Neuronal death versus synaptic pathology in Alzheimer' s disease. Ann N Y Acad Sci 2003;1010:635-638.
DOI
|
22 |
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer' s disease in late onset families. Science 1993;261:921-923.
DOI
|
23 |
Chen CS, Ouyang P, Yeh YC, Lai CL, Liu CK, Yen CF, et al. Apolipoprotein E polymorphism and behavioral and psychological symptoms of dementia in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 2012;26:135-139.
DOI
|
24 |
Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer' s patients and cognitively normal individuals. Neurology 1994;44:1513-1516.
DOI
|
25 |
Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, et al. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer' s disease. Ann Neurol 1996;39:62-70.
DOI
|
26 |
Feskens EJ, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ 1994;309:1202-1206.
DOI
|
27 |
Moon SW, Seo JS, Nam BW, Choi JY, Lee CH, Park KU, et al. An association between apolipoprotein E epsilon4 and cognitive function in community-dwelling elders with questionable dementia. Korean J Biol Psychiatry 2008;15:5-13.
|
28 |
Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer' s disease. Neurology 1993;43:1467-1472.
DOI
|
29 |
Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
DOI
|
30 |
Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer' s Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:P47-P53.
DOI
|
31 |
Kim KW, Jhoo JH, Lee KU, Lee DY, Lee JH, Youn JY, et al. Association between apolipoprotein E polymorphism and Alzheimer' s disease in Koreans. Neurosci Lett 1999;277:145-148.
DOI
|
32 |
Cohen RM, Small C, Lalonde F, Friz J, Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 2001;57:2223-2228.
|
33 |
Helkala EL, Koivisto K, Hanninen T, Vanhanen M, Kervinen K, Kuusisto J, et al. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci Lett 1996;204:177-180.
DOI
|
34 |
Nilsson LG, Adolfsson R, Bäckman L, Cruts M, Nyberg L, Small BJ, et al. The influence of APOE status on episodic and semantic memory: data from a population-based study. Neuropsychology 2006; 20:645-657.
DOI
|
35 |
de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R, Nilsson LG. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J Cogn Neurosci 2005;17:1018-1025.
DOI
|
36 |
Swan GE, Lessov-Schlaggar CN, Carmelli D, Schellenberg GD, La Rue A. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults. J Geriatr Psychiatry Neurol 2005;18:196-201.
DOI
|
37 |
Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 1996;40:55-66.
DOI
|
38 |
Wilson RS, Bienias JL, Berry-Kravis E, Evans DA, Bennett DA. The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry 2002;73:672-677.
DOI
|